close
MENU
Hot Topic EARNINGS
Hot Topic EARNINGS
1 mins to read

Ebos reports healthy full-year result, growth outlook for FY25

Wed, 21 Aug 2024

Dual-listed healthcare product company Ebos has reported a 7.8% rise in revenue to A$13.2 billion for the year ended June 30 2024 with continued strong earnings growth in its healthcare and animal care segments. Net profit was also up 7% to $271 million with the strong performance driven by

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Ebos reports healthy full-year result, growth outlook for FY25
105441
true